The future of patient-centricity in pharmacovigilance involves a dynamic flow of data and information revolving around patients and enabling them — and their caregivers — to make insights-b
The clinical trial industry is hyper-focused on enhancing the participant experience. We’ve seen buzzwords like “patient convenience” and marketing campaigns around “patient centricity”.
While patient centricity remains vital to the life sciences industry, as companies come under pressure to reduce their carbon footprint, we are increasingly seeing different aspects of the
It’s simple: a clinical trial health system that enrols more patients will lead to faster treatment advances and, therefore, better outcomes for people with cancer.1 But, as it s